Particle Sciences Management Team
At Particle Sciences, we take pride in our talented staff. We focus in hiring experienced physicians, engineers, and Doctorate-level surface, analytic, material science and polymer chemists to find practical and creative solutions to your drug development challenges.

Particle Sciences is led by a proven management team that includes:

Mark Mitchnick M.D. - Chief Executive Officer
Robert Lee Ph.D. - VP Pharmaceutical Development and Quality
Bruce Frank Ph.D. - Director Project Management
Andrew Loxley Ph.D. - Director New Technologies
Garry Gwozdz B.S. - Director Formulation
Laurie Goldman B.S. - Director Analytic Services
Hector García B.S. – Director Quality Assurance

The Particle Sciences Team Cumulative Experience
  • MD and PhD's in: Physical Chemistry, Medicinal Chemistry, Synthetic Organic Chemistry, Material Science, Biomaterials, Analytical Chemistry, Colloids and Polymers, Physical Bioorganic Chemistry
  • Broad industry experience
    • Small molecules, oligos, peptides, proteins
    • Multiple therapeutic areas
    • Large pharma, biotech, government, not-for-profit
  • Multiple commercialized technologies
  • Medical Director for Clinical Studies
  • Clinical trial design
  • > 100 patents pending / issued
    • Nanoparticles
    • Emulsions
    • Surface treatments
    • Drug/Device combination products
    • Medical devices
    • Drug delivery
    • Medical algorithms
  • Regulatory
    • US and foreign CMC section support
  • Director level oversight of analytic, quality, formulation, clinical and production groups
  • cGMP manufacturing
    • Semisolids, suspensions, sterile and non-sterile
    • CTM for US and foreign studies
  • Technology Transfer of multiple technologies
  • Nanoparticle design
  • Particle characterization instrument design
  • Many peer reviewed publications
Download the Particle Sciences brochure »
Particle Sciences News »
Particle Sciences by the Numbers
Expert staff holds more than 100 patents
In 2007 alone, PS filed 10 patents for itself and on behalf of its clients
The company has been providing drug development services for nearly two decades
Particle Sciences has developed more than 1,000 formulations
The company occupies 15,000 sq. ft. of laboratory and production space
Particle Sciences has scaled products to >50,000 kg/year

Employment